Search for: "AMGEN INC." Results 541 - 560 of 707
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Aug 2010, 11:03 pm
Cir. 1993); Amgen, Inc. v. [read post]
1 Jul 2010, 1:32 pm by Richard Renner
Grassley letters are available in the continuation of this blog entryBelow are links to the letters sent by Grassley to: Abbott Laboratories Amgen AstraZeneca Pharmaceuticals Boehringer Bristol-Myers Squibb Company Eisai Corporation of America Eli Lilly and Company Forest Laboratories GlaxoSmithKline Hoffman-La Roche Inc. [read post]
2 Jun 2010, 8:50 am
65 Mattel 66 Booz Allen Hamilton 67 Boeing 68 HSBC 69 eBay 70 Hilton Hotels Corporation 71 Siemens 72 Amgen 73 A.T. [read post]
31 May 2010, 8:23 am by Lawrence B. Ebert
SmithKline Beecham Clinical Labs., Inc., 149 F.3d 227, 232-33 (3d Cir. 1998)). [read post]
13 May 2010, 4:44 pm by mcarzima@imediainc.com
  Wisconsin has previously settled with Baxter Healthcare Corp. for $1.05 million, and with Amgen Inc. and Immunex for a total of $2 million. [read post]
16 Apr 2010, 11:55 am by Sonya Hubbard
That’s not the case, however, at Amgen, Inc., (AMGN) the recipient of today’s coveted footnoted gold star. [read post]
15 Apr 2010, 4:27 am
(Spicy IP) Argentina: Argentina’s scientific data laws and TRIPs compliance (IP tango) Chile: Secretary General of International Seed Federation visits Chile, pressures nation to sign UPOV 91 (IP tango) EU: AHP Manufacturing BV v Bureau voor de Industriële Eigendom analysis now in print (The SPC Blog) Hungary: Metropolitan Appeal Court: Preliminary injunction refused concerning combination patent (EPLAW) Hungary: Metropolitan Appeal Court of Budapest upholds decision of Metropolitan… [read post]
12 Apr 2010, 11:10 pm
Amgen, Inc., 475 F.3d 1256, 1263 (Fed. [read post]
9 Apr 2010, 7:17 am by Lawrence B. Ebert
It is not sufficient to define it solely by its principal biological property.'" American BioScience, 333 F.3d at 1340 (quoting Amgen Inc. v. [read post]
8 Apr 2010, 5:21 pm
Cir. 1994) and Amgen, Inc. v. [read post]
8 Mar 2010, 10:37 am by Kyle Fleming
Amgen Inc., 475 F.3d 1256, 1264–65 (Fed. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]